In 2014, MAPS spun out a individual division to direct study and prepare for an eventual FDA software, which it submitted at the conclusion of very last year. In early 2024, that offshoot was renamed Lykos Therapeutics.Though not about serotonin, copyright also brings about a spike in dopamine and adrenaline activation in the Mind. The drug’s ene… Read More